If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACC.L Regulatory News (ACC)

  • There is currently no data for ACC

Trading Update

18 Jun 2020 07:00

RNS Number : 2923Q
Access Intelligence PLC
18 June 2020
 

Access Intelligence plc

("Access Intelligence" or the "Company")

Trading Update

Access Intelligence (AIM: ACC), the technology innovator delivering Software-as-a-Service ("SaaS") solutions for the PR, communications and marketing industries, announces an update on trading for the six months ended 31 May 2020.

 

The Company's underlying business has performed well through the volatility seen in the first half of the year with strong renewal rates underpinning growth in Annual Contract Value ('ACV') of £1.04m in the period, over double the £0.45m increase for the equivalent period in 2019. This equates to organic annualised ACV growth of 12% and, importantly, all sub brands delivered double digit growth.

 

The Board anticipates total revenue to be £9.4m for the period, a year on year increase of over 50%. Excluding the acquisition of Pulsar, revenue grew by 10%. The Company also implemented a number of cost saving initiatives and the impact of these measures is expected to result in costs being reduced by approximately £1.1m this year. As a result of the comprehensive and rapid response taken by the Company to the COVID-19 disruption, its liquidity position remains strong with net cash of £2.6m at 31 May 2020 compared to £2.0m at 30 November 2019.

 

The Company reacted quickly to establish processes that enabled a successful transition to remote working that protected both the health and safety of staff but also prevented any disruption to client service or product development. The changes were made without impacting the longer-term growth prospects of the business, with cost saving measures including the Company furloughing approximately 15% of staff, salary and fee reductions for the Board and employees for three months, and the curtailment of discretionary spending.

 

Alongside the strong performance in renewal rates the period also saw new business success with clients added including global brands spanning the public, private and charity sectors. New clients wins included Aegon, Allen & Overy, Astra-Zeneca, Chanel, the Co-operative Group, Lotus, Ministry of Justice, Nintendo, OFGEM and the WWF. In the USA, Pulsar won new clients including Dow Jones, the International Monetary Fund, Levi Strauss and Twitter. The wins reflect the improved product portfolio which, since the addition of Pulsar in October 2019, has been strengthened to open up new sectors and international opportunities.

 

The Company continues to actively pursue new business opportunities and remains encouraged by its ongoing pipeline development. Nonetheless COVID-19 has inevitably affected the rate of new business wins as potential new customers put certain projects on hold and delayed investing in new technology products.

 

Given the dynamic nature of the situation it remains hard to predict how our pipeline of opportunities will evolve over the remainder of the year. The uncertainty means that whilst the resilience and strength that the business showed in the first half is very satisfactory and 93% of revenue is recurring, the Company's ability to generate new business in line with our original 2020 expectations remains unclear. Therefore, the Board considers it inappropriate to provide forward-looking guidance until the overall impact of COVID-19 becomes clearer.

 

Christopher Satterthwaite, Non-Executive Chairman of the Company, said: "Despite the challenge COVID-19 has presented all businesses, the last six months trading has demonstrated the strength of the Company with encouraging growth seen across the product portfolio. The strengthening of the portfolio with Pulsar will accelerate growth and by diversifying the product, sector and territorial opportunities, contribute to the Company's overall resilience."

 

 

Enquiries:

Access Intelligence plc

020 3426 4024

Joanna Arnold, CEO

Mark Fautley, CFO

finnCap Limited (Nominated Adviser and Broker)

020 7220 0500

Corporate Finance:

Marc Milmo/Kate Bannatyne/Matthew Radley

 

Corporate Broking:

Alice Lane/Sunila de Silva

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFLFMWESSEEM
Date   Source Headline
22nd Sep 20117:00 amRNSCobent Vendor Arrangements and Trading Update
22nd Aug 20114:25 pmRNSDirector/PDMR Shareholding
11th Jul 20117:00 amRNSNotice of Results
4th Jul 20117:00 amRNSSale of Solcara Limited
27th May 201112:16 pmRNSAnnual Report and Accounts
4th Apr 201112:45 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
31st Jan 20117:28 amRNSManagement Update
16th Dec 20107:00 amRNSTrading Update and Directorate Change
3rd Nov 20107:00 amRNSNominated adviser and broker change of name
31st Aug 20107:00 amRNSIssue of equity on conversion of Loan Notes
19th Jul 20107:00 amRNSHalf Yearly Report
23rd Jun 20107:00 amRNSNotice of Results
14th Apr 201012:55 pmRNSResult of AGM
31st Mar 20107:00 amRNSHolding(s) in Company
25th Mar 201012:08 pmRNSDirector Dealing and Exercise of Options
25th Mar 20107:50 amRNSNotice of AGM
3rd Mar 20106:26 pmRNSHolding(s) in Company
3rd Mar 20103:22 pmRNSIssue of Equity
2nd Mar 20109:06 amRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSAcquisition
1st Mar 20107:00 amRNSPreliminary Results
23rd Feb 20107:00 amRNSNotice of results meeting
12th Jan 20107:00 amRNSTrading Statement
2nd Nov 20099:08 amRNSDirector/PDMR Shareholding
6th Oct 20098:52 amRNSIssue of Share Options
29th Jul 20091:30 pmRNSResult of General Meeting
10th Jul 20097:00 amRNSAdditional Convertible Loan Notes
1st Jul 20097:00 amRNSAcquisition and Convertible Loan Note
24th Jun 20097:00 amRNSHalf Yearly Report
15th Jun 20097:00 amRNSChange of Name of Nominated Adviser and Broker
1st May 20092:52 pmRNSResult of AGM
23rd Mar 20097:00 amRNSFinal Results
22nd Dec 20087:00 amRNSTotal Voting Rights
12th Dec 20087:00 amPRNDirectorate Change
9th Dec 20087:00 amRNSIssue of Equity
19th Nov 20087:00 amPRNShareholder Information
5th Nov 20087:01 amPRNDirectorate Change
5th Nov 20087:00 amRNSDisposal
5th Nov 20087:00 amPRNAcquisition of Solcara
31st Oct 20087:00 amPRNTotal Voting Rights
27th Oct 20087:00 amPRNDirectorate Change
20th Oct 200810:42 amPRNResult of EGM
24th Sep 20087:00 amRNSBoard Changes & Subscription
6th Aug 20087:00 amRNSInterim Results
21st Jul 20087:00 amRNSNotice of Results
6th Jun 20087:00 amRNSTrading Statement
5th Jun 20085:53 pmRNSTrading Statement
12th Mar 20087:00 amRNSChange in Shareholding
6th Mar 20087:00 amPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.